icon-circle-smiley-face

News Links

Popular Press News for April 5, 2017

Gore joins ViaCyte’s quest for a functional type 1 diabetes cure. Diabetic UB hockey player looks to maintain lifestyle. Tom Miller: Carr keeps running to inspire others. First type 1 diabetic given go-ahead to race. 17-year-old girl with type 1 diabetes accused of cheating after taking her blood glucose monitor into driving theory test. Diabetes: Kids and Type 1 Diabetes. Is It Insulin Worthy? OpenAPS Offers Open Source Tools for Diabetes Management.

Read More

Legislative and Policy News for April 5, 2017

Medicare and Diabetes: What is Covered? Getting More Glucose Test Strips on a Budget.

Read More

Celiac News for April 5, 2017

Persistence of Non-Celiac Wheat Sensitivity, Based on Long-term Follow Up. ImmusanT’s celiac disease immunotherapy passes first clinical test.

Read More

Daily Care News for April 5, 2017

Relative effectiveness of insulin pump treatment over multiple daily injections and structured education during flexible intensive insulin treatment for type 1 diabetes: cluster randomized trial (REPOSE). Free full text available in PDF format. See also Unique trial compares insulin pump to MDI treatment in type 1 diabetes. Fast-Acting Insulin Aspart Improves Glycemic Control in Basal-Bolus Treatment for Type 1 Diabetes: Results of a 26-Week Multicenter, Active-Controlled, Treat-to-Target, Randomized, Parallel-Group Trial (Onset 1). Faster insulin action is associated with improved glycemic outcomes during closed-loop insulin delivery and sensor-augmented pump therapy in adults with type 1 diabetes. The Stress and Coping Context of Type 1 […]

Read More

Social Media News for April 5, 2017

Guest Post: My Magical Disney Moment. 8 Tips For a Successful Snowboarding Weekend With Diabetes. Diabetes Experts on How to Stop Eating at Night. Mental Health Providers and Diabetes: We Need Better Access. Trying to Make it to the Show with Type 1 Diabetes. The High Costs of Diabetes Kills: RIP, Shane Patrick Boyle.

Read More

Press Releases for March 29, 2017

Medicare Announces Criteria Covering Dexcom G5 Mobile CGM for All People with Diabetes on Intensive Insulin Therapy. DCU Researchers make significant diabetes finding with 3U Diabetes Consortium.

Read More

Popular Press for March 29, 2017

Woman goes into diabetic shock, turns to Facebook friends for help. Athlete with Type 1 diabetes tells of marathon motivation. Boy walks 4,000 miles to help cure diabetes. Teddy Bear Hospital helps kids with type 1 diabetes. A hockey camp for kids suffering from diabetes. ‘Insulin Superheroes’ program reduces HbA1c in children.

Read More

Legislative and Policy News for March 29, 2017

Mitigating out-of-pocket costs for prescription drugs. Wyden Introduces Bill to Increase Transparency of PBMs.

Read More

Celiac News for March 29, 2017

Greater postprandial glucose excursions and inadequate nutrient intake in youth with type 1 diabetes and celiac disease. Free full text available in HTML and PDF formats. Screening for Celiac Disease: US Preventive Services Task Force Recommendation Statement. The US Preventive Services Task Force Recommendation on Screening for Asymptomatic Celiac Disease: A Dearth of Evidence. No Need To Get Screened For Celiac Unless You Have Symptoms, Panel Says. The effects of modified versus unmodified wheat gluten administration in patients with celiac disease.

Read More

Daily Care News for March 29, 2017

Prevention of Hypoglycemia With Predictive Low Glucose Insulin Suspension in Children With Type 1 Diabetes: A Randomized Controlled Trial. Expectations and Attitudes of Individuals With Type 1 Diabetes After Using a Hybrid Closed Loop System. Comparative study on treatment satisfaction and health perception in children and adolescents with type 1 diabetes mellitus on multiple daily injection of insulin, insulin pump and sensor-augmented pump therapy. Free full text available in HTML and PDF formats. Short-term Effects of Low Carbohydrate Diet on Glycaemic Parameters and Cardiovascular Risk Markers in Patients with Type 1 Diabetes – A Randomized Open-label Cross-over Trial. An additional bolus of rapid-acting insulin […]

Read More